For at differentiere mellem stigninger i aminotransferaser på grund af respons på behandling og stigninger, der kan være forbundet med lactacidose, bør lægen sikre sig, at stigningerne i ALAT er forbundet med forbedringer i andre laboratoriemarkører for kronisk hepatitis B.
To differentiate between elevations in aminotransferases due to response to treatment and increases potentially related to lactic acidosis, physicians should ensure that changes in ALT are associated with improvements in other laboratory markers of chronic hepatitis B.